Finnish Perspective on Drug-Impaired Driving Finds Cannabis Among Top Substances Detected
Review of drug-impaired driving policies and data across Europe found illicit drug prevalence of 1-5% among general drivers, with cannabis, amphetamines, benzodiazepines, and opiates among the most concerning substances for driving safety.
Quick Facts
What This Study Found
This review examined drug-impaired driving from a Finnish and European perspective. It reported that the prevalence of illicit drug use among the general driving population in Europe ranged from 1-5%, while licit drugs affecting driving (particularly benzodiazepines) had a prevalence of 5-10%.
Drugs identified as most concerning for driving impairment included amphetamines, cocaine, cannabis, opiates, and benzodiazepines. The review discussed evolving legal frameworks, noting that some countries had introduced zero-tolerance per se laws that prohibit driving with any detectable level of illicit drugs or metabolites, regardless of demonstrated impairment.
The review also discussed advancing roadside testing technology, including oral fluid (saliva) testing. Legislation in Victoria, Australia already allowed oral fluid testing for cannabis and methamphetamine, though blood testing remained the most common form of evidentiary testing in most jurisdictions.
Key Numbers
Illicit drug prevalence in European general driving population: 1-5%. Licit drug prevalence affecting driving: 5-10%. Most concerning drugs: amphetamines, cocaine, cannabis, opiates, benzodiazepines. Some countries adopted zero-tolerance per se laws.
How They Did This
Review article examining drug-impaired driving from a Finnish perspective, covering prevalence data, legal frameworks across countries, detection methods (blood, oral fluid, urine), and enforcement approaches. Drew on epidemiological data from drivers, offenders, and crash-involved populations.
Why This Research Matters
As cannabis legalization has expanded since this review, the question of drug-impaired driving has become increasingly important. The distinction between zero-tolerance approaches (any detectable level) and impairment-based approaches (demonstrated functional impairment) remains a central policy debate.
The Bigger Picture
The debate over how to define and enforce drug-impaired driving has only intensified as more jurisdictions legalize cannabis. The fundamental challenge remains: unlike alcohol, there is no established relationship between blood THC levels and degree of driving impairment, making per se limits controversial.
What This Study Doesn't Tell Us
The review focused on the Finnish and European context, which may not generalize to other regions. Data on drug prevalence among drivers varied in quality across countries. The review did not establish specific impairment thresholds for individual drugs.
Questions This Raises
- ?Can roadside testing technology reliably detect cannabis impairment as opposed to mere recent use?
- ?Is a zero-tolerance approach or an impairment-based approach more effective for cannabis-impaired driving enforcement?
Trust & Context
- Key Stat:
- 1-5% of European drivers tested positive for illicit drugs; 5-10% for licit drugs affecting driving
- Evidence Grade:
- Review article compiling epidemiological data and policy analysis from multiple European countries. Provides a broad overview but limited by varying data quality across jurisdictions.
- Study Age:
- Published in 2005. Drug-impaired driving detection technology and legislation have evolved substantially since then, particularly as cannabis legalization has expanded.
- Original Title:
- Drugs and driving: the Finnish perspective.
- Published In:
- Bulletin on narcotics, 57(1-2), 213-29 (2005)
- Authors:
- Lillsunde, P, Gunnar, T
- Database ID:
- RTHC-00196
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How common is drug-impaired driving?
This review estimated 1-5% of European general population drivers tested positive for illicit drugs, with another 5-10% positive for licit drugs that affect driving ability (primarily benzodiazepines). Rates were higher among those involved in crashes or suspected of impaired driving.
Can police test for cannabis at the roadside?
As of 2005, some jurisdictions (notably Victoria, Australia) had implemented oral fluid roadside testing for cannabis. Most countries still relied on blood testing for evidentiary purposes. Roadside detection technology has continued to advance since then.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
- pulled-over-with-weed-in-car
- cannabis-dui-laws-impairment-testing-penalties
- does-thc-affect-driving-impairment-science
- cannabis-consumption-method-quiz-find-your-fit
- what-consumption-method-right-for-you-quiz
Cite This Study
https://rethinkthc.com/research/RTHC-00196APA
Lillsunde, P; Gunnar, T. (2005). Drugs and driving: the Finnish perspective.. Bulletin on narcotics, 57(1-2), 213-29.
MLA
Lillsunde, P, et al. "Drugs and driving: the Finnish perspective.." Bulletin on narcotics, 2005.
RethinkTHC
RethinkTHC Research Database. "Drugs and driving: the Finnish perspective." RTHC-00196. Retrieved from https://rethinkthc.com/research/lillsunde-2005-drugs-and-driving-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.